-
1
-
-
33750432183
-
Nuclear factorkappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression
-
Basseres DS, Baldwin AS: Nuclear factorkappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 2006; 25: 6817-6830.
-
(2006)
Oncogene
, vol.25
, pp. 6817-6830
-
-
Basseres, D.S.1
Baldwin, A.S.2
-
2
-
-
0027184023
-
The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers
-
Fujita T, Nolan GP, Liou HC, Scott ML, Baltimore D: The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev 1993; 7(7B):1354-1363.
-
(1993)
Genes Dev
, vol.7
, Issue.7 B
, pp. 1354-1363
-
-
Fujita, T.1
Nolan, G.P.2
Liou, H.C.3
Scott, M.L.4
Baltimore, D.5
-
3
-
-
0035137882
-
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB
-
Baldwin AS: Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 2001; 107: 241-246.
-
(2001)
J Clin Invest
, vol.107
, pp. 241-246
-
-
Baldwin, A.S.1
-
4
-
-
54949085398
-
Kras mutations and benefit from cetuximab in advanced colorectal cancer
-
Karapetis CS, Khambata-Ford S, Jonker DJ, OCallaghan CJ, Tu D, Tebbutt NC, et al: Kras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 2008; 359: 1757-1765.
-
(2008)
N Engl J Med
, vol.359
, pp. 1757-1765
-
-
Karapetis, C.S.1
Khambata-Ford, S.2
Jonker, D.J.3
Ocallaghan, C.J.4
Tu, D.5
Tebbutt, N.C.6
-
5
-
-
0035868342
-
Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/ Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN
-
Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE: Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/ Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene 2001; 20: 1287-1299.
-
(2001)
Oncogene
, vol.20
, pp. 1287-1299
-
-
Pianetti, S.1
Arsura, M.2
Romieu-Mourez, R.3
Coffey, R.J.4
Sonenshein, G.E.5
-
6
-
-
0033517189
-
NF-kappaB activation by tumor necrosis factor requires the Akt serine-threonine kinase
-
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB: NF-kappaB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 1999; 401: 82-85.
-
(1999)
Nature
, vol.401
, pp. 82-85
-
-
Ozes, O.N.1
Mayo, L.D.2
Gustin, J.A.3
Pfeffer, S.R.4
Pfeffer, L.M.5
Donner, D.B.6
-
7
-
-
0034961050
-
Roles of Akt/ PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/ c-myc transgenic mice
-
Factor V, Oliver AL, Panta GR, Thorgeirsson SS, Sonenshein GE, Arsura M: Roles of Akt/ PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/ c-myc transgenic mice. Hepatology 2001; 34: 32-41.
-
(2001)
Hepatology
, vol.34
, pp. 32-41
-
-
Factor, V.1
Oliver, A.L.2
Panta, G.R.3
Thorgeirsson, S.S.4
Sonenshein, G.E.5
Arsura, M.6
-
8
-
-
0030882666
-
Oncogenic Ha-Rasinduced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation
-
Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Baldwin AS Jr: Oncogenic Ha-Rasinduced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J Biol Chem 1997; 272: 24113-24116.
-
(1997)
J Biol Chem
, vol.272
, pp. 24113-24116
-
-
Finco, T.S.1
Westwick, J.K.2
Norris, J.L.3
Beg, A.A.4
Der, C.J.5
Baldwin Jr., A.S.6
-
9
-
-
33644853585
-
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma
-
Izzo JG, Malhotra U, Wu TT, Ensor J, Luthra R, Lee JH, et al: Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma. J Clin Oncol 2006; 24: 748-754.
-
(2006)
J Clin Oncol
, vol.24
, pp. 748-754
-
-
Izzo, J.G.1
Malhotra, U.2
Wu, T.T.3
Ensor, J.4
Luthra, R.5
Lee, J.H.6
-
10
-
-
34548536941
-
Nuclear factor-κ B tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy
-
Scartozzi M, Bearzi I, Pierantoni C, Mandolesi A, Loupakis F, Zaniboni A, et al: Nuclear factor-κ B tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy. J Clin Oncol 2007; 25: 3930-3935.
-
(2007)
J Clin Oncol
, vol.25
, pp. 3930-3935
-
-
Scartozzi, M.1
Bearzi, I.2
Pierantoni, C.3
Mandolesi, A.4
Loupakis, F.5
Zaniboni, A.6
-
11
-
-
0034708132
-
Selective activation of NF-kappa B subunits in human breast cancer: Potential roles for NF-kappa B2/p52 and for Bcl-3
-
Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS Jr: Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 2000; 19: 1123-1131.
-
(2000)
Oncogene
, vol.19
, pp. 1123-1131
-
-
Cogswell, P.C.1
Guttridge, D.C.2
Funkhouser, W.K.3
Baldwin Jr., A.S.4
-
12
-
-
37049004740
-
Expression of nuclear factor-kappaB family proteins in hepatocellular carcinomas
-
O'Neil BH, Buzkova P, Farrah H, Kashatus D, Sanoff H, Goldberg RM, et al: Expression of nuclear factor-kappaB family proteins in hepatocellular carcinomas. Oncology 2007; 72: 97-104.
-
(2007)
Oncology
, vol.72
, pp. 97-104
-
-
O'Neil, B.H.1
Buzkova, P.2
Farrah, H.3
Kashatus, D.4
Sanoff, H.5
Goldberg, R.M.6
-
13
-
-
0027446955
-
The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers
-
Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, et al: The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell 1993; 72: 729-739.
-
(1993)
Cell
, vol.72
, pp. 729-739
-
-
Bours, V.1
Franzoso, G.2
Azarenko, V.3
Park, S.4
Kanno, T.5
Brown, K.6
-
14
-
-
0027472317
-
The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are i kappa B molecules and control nuclear translocation of NF-kappa B
-
Naumann M, Wulczyn FG, Scheidereit C: The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B. EMBO J 1993; 12: 213-222.
-
(1993)
EMBO J
, vol.12
, pp. 213-222
-
-
Naumann, M.1
Wulczyn, F.G.2
Scheidereit, C.3
-
15
-
-
14644422665
-
Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers
-
Zhou Y, Eppenberger-Castori S, Marx C, Yau C, Scott GK, Eppenberger U, et al: Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers. Int J Biochem Cell Biol 2005; 37: 1130-1134.
-
(2005)
Int J Biochem Cell Biol
, vol.37
, pp. 1130-1134
-
-
Zhou, Y.1
Eppenberger-Castori, S.2
Marx, C.3
Yau, C.4
Scott, G.K.5
Eppenberger, U.6
-
16
-
-
17844368327
-
The MAPK signaling pathways and colorectal cancer
-
Fang J, Richardson B: The MAPK signaling pathways and colorectal cancer. Lancet Oncol 2005; 6: 322-337.
-
(2005)
Lancet Oncol
, vol.6
, pp. 322-337
-
-
Fang, J.1
Richardson, B.2
-
17
-
-
0033517190
-
NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling
-
Romashkova JA, Makarov SS: NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 1999; 401: 86-90.
-
(1999)
Nature
, vol.401
, pp. 86-90
-
-
Romashkova, J.A.1
Makarov, S.S.2
-
18
-
-
0033961280
-
Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB
-
Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr, Mayo MW: Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 2000; 20: 1626-1638.
-
(2000)
Mol Cell Biol
, vol.20
, pp. 1626-1638
-
-
Madrid, L.V.1
Wang, C.Y.2
Guttridge, D.C.3
Schottelius, A.J.4
Baldwin Jr., A.S.5
Mayo, M.W.6
-
19
-
-
0033553466
-
Oncogenic Ras enhances NF-kappaB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways
-
Norris JL, Baldwin AS Jr: Oncogenic Ras enhances NF-kappaB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways. J Biol Chem 1999; 274: 13841-13846.
-
(1999)
J Biol Chem
, vol.274
, pp. 13841-13846
-
-
Norris, J.L.1
Baldwin Jr., A.S.2
-
20
-
-
0032514363
-
Activation of NF-kappa B by oncogenic Raf in HEK cells occurs through autocrine recruitment of the stress kinase cascade
-
Troppmair J, Hartkamp J, Rapp UR: Activation of NF-kappa B by oncogenic Raf in HEK cells occurs through autocrine recruitment of the stress kinase cascade. Oncogene 1998; 17: 685-690.
-
(1998)
Oncogene
, vol.17
, pp. 685-690
-
-
Troppmair, J.1
Hartkamp, J.2
Rapp, U.R.3
-
21
-
-
77954243178
-
NF-κB is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiation
-
in press
-
O'Neil B: NF-κB is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiation. Int J Radiat Oncol Biol Phys, in press.
-
Int J Radiat Oncol Biol Phys
-
-
O'Neil, B.1
|